A Prospective, Double-blind, Randomized Study to Compare Efficacy of Two Etanercept Regimens (REUMATOCEPT; Versus ENBREL) for Treatment of Rheumatoid Arthritis.

Trial Profile

A Prospective, Double-blind, Randomized Study to Compare Efficacy of Two Etanercept Regimens (REUMATOCEPT; Versus ENBREL) for Treatment of Rheumatoid Arthritis.

Suspended
Phase of Trial: Phase III

Latest Information Update: 01 Mar 2013

At a glance

  • Drugs Etanercept (Primary)
  • Indications Rheumatoid arthritis
  • Focus Registrational; Therapeutic Use
  • Sponsors EMS Sigma Farma
  • Most Recent Events

    • 01 Mar 2013 Planned End Date changed from 1 Jun 2012 to 1 Jun 2014 as reported by ClinicalTrials.gov.
    • 01 Mar 2013 Status changed from not yet recruiting to suspended as reported by ClinicalTrials.gov.
    • 18 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top